🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
In this research study, the investigators are evaluating the clinical benef...
Status
Completed
Location
Dana Farber Cancer Institute
Start Date
2014-09
Trial ID
NCT02201212
Treatments Being Tested
The primary objective of the study is to evaluate the safety of idelalisib ...
Status
Completed
Location
Clearview Cancer Institute
Start Date
2010-03-25
Trial ID
NCT01088048
RAD001 continues to be investigated as an anticancer agent on new indicatio...
Status
Unknown
Location
Guangdong Lung Cancer Institute, Guangdong General Hospital & Guangdong Academy of Medical Sciences
Start Date
2010-07
Trial ID
NCT01175096
Treatments Being Tested
RATIONALE: Everolimus may stop the growth of tumor cells by blocking some o...
Status
Unknown
Location
Leiden University Medical Center
Start Date
2010-05
Trial ID
NCT01118065
Treatments Being Tested
This clinical pharmacology research study will assess the safety and pharma...
Status
Completed
Location
Novartis Investigative Site
Start Date
2009-11
Trial ID
NCT00968591
Treatments Being Tested
The goal of this clinical research study is to find the highest tolerable d...
Status
Completed
Location
University of Texas MD Anderson Cancer Center
Start Date
2012-12-18
Trial ID
NCT01596140
Treatments Being Tested
This randomized phase II trial studies the effects, good and bad, of using ...
Status
Active Not Recruiting
Location
Mayo Clinic in Florida
Start Date
2014-10-09
Trial ID
NCT02143726
Treatments Being Tested
This trial studies whether Everolimus is efficacious in treating neurofibro...
Status
Completed
Location
New York University Medical Center
Start Date
2011-10
Trial ID
NCT01419639
Treatments Being Tested
This study will evaluate the role of everolimus in combination with local T...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2011-06
Trial ID
NCT01379521
Treatments Being Tested
Study has two parts: 1. Dose-finding: to determine the maximum tolerated d...
Status
Completed
Location
Highlands Oncology Group Dept of Highlands Oncology Grp
Start Date
2012-01
Trial ID
NCT01482156
Treatments Being Tested